vaccin
essenti
control
diseas
livestock
companion
zoo
anim
wildlif
control
fertil
diseas
pest
speci
effect
mucos
vaccin
myriad
advantag
parenter
vaccin
share
across
human
veterinari
speci
instanc
mucos
vaccin
stimul
mucos
system
immun
system
mean
mucos
vaccin
reduc
pathogen
colon
shed
thu
protect
popul
herd
infect
major
challeng
mucos
immun
gener
effect
immun
instead
immunolog
toler
well
overcom
interfer
passiv
acquir
matern
antibodi
oral
toler
suppress
mechan
design
prevent
host
immun
system
overreact
innocu
antigen
present
feed
commens
flora
oral
toler
induc
subsequ
exposur
antigen
mucos
system
rout
prevent
induct
robust
immun
respons
vast
major
mucos
vaccin
use
live
attenu
form
pathogen
replic
target
speci
avoid
induct
oral
toler
rare
circumst
may
revert
back
virul
form
live
vaccin
includ
virus
replicationdefici
adenoviru
canarypox
viru
carrier
vaccin
other
act
vector
express
gene
interest
variou
pathogen
carrier
virus
abil
limit
abil
replic
immun
speci
revers
replic
compet
highli
infecti
viru
possibl
make
safer
vaccin
choic
report
mucos
deliveri
live
viral
vaccin
upper
respiratori
tract
may
overcom
matern
antibodi
interfer
previou
chapter
provid
detail
analys
numer
advantag
mucos
vaccin
discuss
depth
instead
aspect
mucos
vaccin
develop
particularli
import
veterinari
field
mass
deliveri
vaccin
differenti
infect
vaccin
import
trade
implic
econom
consider
discuss
exampl
numer
commerci
avail
mucos
veterinari
vaccin
discuss
novel
experiment
vaccin
provid
vaccin
develop
administr
veterinari
speci
protect
human
health
also
discuss
mass
deliveri
method
mucos
immun
administr
vaccin
drink
water
feed
spray
avian
speci
ingest
preen
ovo
avian
speci
immers
aquat
speci
allow
vaccin
hundr
thousand
anim
short
period
time
import
mass
deliveri
mucos
vaccin
mean
individu
anim
need
restrain
extrem
stress
anim
especi
routin
handl
human
restraint
may
potenti
hazard
person
team
peopl
administ
vaccin
major
drawback
mass
deliveri
uniform
dose
per
anim
alway
given
across
popul
mucos
rout
requir
restraint
vaccin
administ
intranas
drench
oral
immun
syring
eyedrop
conjunctiv
administr
deliveri
method
advantag
promot
mucos
immun
respons
dose
per
anim
easili
control
requir
anim
restraint
make
expens
deliv
today
global
economi
trade
anim
anim
product
meat
egg
fur
occur
local
nation
intern
trade
purpos
advantag
abl
distinguish
anim
infect
diseas
anim
vaccin
vaccin
allow
immunolog
differenti
anim
infect
vaccin
call
diva
vaccin
diva
vaccin
often
lack
one
protein
present
wildtyp
microorgan
determin
immun
assay
firstgener
diva
vaccin
develop
discov
pig
vaccin
attenu
strain
aujeszki
diseas
viru
develop
antibodi
select
protein
epitop
wherea
anim
infect
wildtyp
virus
proteinspecif
antibodi
serum
firstgener
marker
vaccin
soon
improv
upon
use
genet
modifi
live
vaccin
lack
select
glycoprotein
enzymelink
immun
sorbent
assay
develop
could
determin
pig
vaccin
lack
antibodi
glycoprotein
antibodi
specif
prv
protein
use
strain
vaccin
genet
engin
live
viral
vaccin
research
could
track
success
erad
effort
result
effect
erad
program
diseas
mani
part
europ
without
option
use
diva
vaccin
produc
may
choos
vaccin
avoid
presenc
antibodi
herd
guarante
due
vaccin
presenc
diseasecaus
agent
herd
time
vaccin
made
live
virus
replicationdefici
adenoviru
express
gene
interest
variou
pathogen
modifi
virus
select
gene
delet
consid
genet
modifi
organ
gmo
anim
vaccin
gmo
may
face
regulatori
hurdl
must
overcom
product
anim
sold
inde
countri
reluct
licens
gmo
vaccin
livestock
product
largescal
busi
mucos
vaccin
implement
unless
diseas
caus
signific
mortal
andor
morbid
product
metric
neg
affect
vaccin
use
suffici
afford
use
significantli
reduc
profit
depend
diseas
easili
spread
well
infecti
agent
surviv
environ
cull
barn
rather
mass
vaccin
may
econom
feasibl
option
clear
infect
howev
welfar
point
view
practic
highli
problemat
often
result
public
outcri
moreov
antimicrobialresist
pathogen
continu
emerg
increas
pressur
rais
livestock
reduc
level
antibiot
vaccin
offer
potenti
control
infect
repres
effect
altern
antibiot
togeth
adapt
mucos
vaccin
mass
deliveri
livestock
diva
vaccin
impact
trade
consider
cost
vaccin
develop
implement
influenc
whether
vaccin
use
veterinari
set
whether
effect
vaccin
gener
infecti
agent
requir
extens
knowledg
diseas
pathogenesi
epidemiolog
across
target
speci
livestock
cattl
rumin
pig
avian
speci
chicken
turkey
etc
companion
anim
hors
dog
cat
rabbit
guinea
pig
etc
wildlif
deer
bison
koala
etc
pest
speci
skunk
raccoon
mice
rat
etc
zoo
anim
aquat
speci
uniqu
econom
social
immunolog
characterist
affect
whether
mucos
vaccin
sought
develop
whether
exist
mucos
vaccin
use
grow
human
popul
lead
increas
need
protein
food
anim
anim
byproduct
led
steadi
increas
number
intens
livestock
oper
worldwid
oper
includ
hundr
thousand
anim
contain
pastur
barn
close
proxim
one
anoth
facilit
spread
diseas
vulner
member
within
popul
mucos
vaccin
superior
system
vaccin
prevent
colon
shed
pathogen
mucos
vaccin
especi
import
control
infect
livestock
tremend
stride
made
veterinari
mucos
vaccin
develop
commerci
avail
mani
list
tabl
follow
section
provid
exampl
mucos
veterinari
vaccin
develop
select
pathogen
use
anim
target
speci
rather
mice
experiment
anim
possibl
diarrhea
newborn
piglet
dna
vaccin
express
protein
virus
deliv
attenu
salmonella
typhimurium
construct
potenti
vaccin
immunogen
assess
twentyonedayold
piglet
oral
immun
attenu
typhimurium
empti
dna
vaccin
dna
vaccin
express
protein
dosag
cfu
per
piglet
booster
immun
cfu
week
virusneutr
sproteinspecif
immunoglobulin
g
igg
secretori
immunoglobulin
siga
well
system
cellular
immun
respons
interferon
gamma
interleukin
lymphocyt
prolifer
significantli
higher
vaccin
group
control
empti
dna
vaccin
cohort
data
show
typhimurium
use
carri
dna
vaccin
deliv
oral
may
promot
protect
immun
respons
brucella
ovi
ovin
epididym
caus
brucella
ovi
infect
report
america
european
countri
australia
new
zealand
south
africa
diseas
lead
genit
lesion
reduc
fertil
ram
placent
abort
ewe
increas
perinat
mortal
lamb
safer
subcutan
vaccin
conjunctiv
vaccin
live
brucella
melitensi
rev
vaccin
caus
abort
highli
virul
diva
vaccin
therefor
recommend
countri
free
b
melitensi
altern
conjunctiv
immun
ram
use
thermorespons
mucoadhes
situ
gel
compos
poloxam
chitosan
ch
could
effect
deliv
recombin
bl
part
enzym
lumazin
synthas
brucella
spp
highli
immunogen
carrier
foreign
peptid
b
ovi
antigen
serum
preputi
saliva
lacrim
nasal
secret
show
signific
antigenspecif
igg
antibodi
level
remain
elev
serum
sever
month
rel
unvaccin
ram
ram
vaccin
cohort
show
signific
induct
antigenspecif
siga
first
second
immun
lacrim
preputi
nasal
secret
nasal
secret
serum
antibodi
level
declin
rapidli
conjunctiv
immun
induc
signific
hypersensit
respons
intraderm
inject
rel
control
ram
indic
induct
cellmedi
immun
conjunctiv
administr
may
promis
altern
current
b
ovi
immun
strategi
bovin
herpesviru
respons
infecti
bovin
rhinotrach
infecti
pustular
vulvovagin
conjunct
abort
encephalomyel
mastiti
cattl
parenter
glycoprotein
e
delet
mutant
viral
diva
vaccin
use
conjunct
diagnost
test
target
cull
anim
infect
field
strain
led
erad
diseas
european
countri
addit
diva
mucos
vaccin
develop
exampl
small
trial
show
calv
vaccin
intranas
glycoprotein
e
delet
mutant
viru
tripl
mutant
viru
tmv
incorpor
mutat
three
gene
includ
glycoprotein
e
within
singl
viru
protect
infecti
challeng
diva
vaccin
protect
clinic
diseas
tmvvaccin
calv
gener
significantli
higher
virusneutr
titer
challeng
rel
sham
control
show
rapid
cellular
immun
respons
onset
rapid
viral
clearanc
although
viru
worldwid
distribut
use
marker
vaccin
continu
contribut
erad
effort
water
buffalo
cattl
bison
affect
hemorrhag
septicemia
hs
acut
highli
fatal
form
pasteurellosi
econom
import
bacteri
diseas
affect
asia
africa
middl
east
sporad
outbreak
occur
southern
europ
hs
vaccin
contain
avirul
pasteurella
multocida
strain
fallow
deer
strain
use
myanmar
control
hs
cattl
water
buffalo
earlier
intranas
vaccin
fail
protect
subcutan
challeng
efficaci
vaccin
primari
vaccin
young
buffalo
brought
question
howev
later
studi
show
intranas
vaccin
contain
live
gdhaderiv
p
multocida
boost
week
later
protect
subcutan
administ
challeng
live
wildtyp
p
multocida
importantli
vaccin
also
effect
protect
incontact
buffalo
virul
parent
strain
recommend
food
agricultur
organ
unit
nation
effect
vaccin
asia
calv
receiv
matern
antibodi
utero
instead
receiv
antibodi
colostrum
neonat
period
howev
matern
antibodi
critic
requir
protect
vulner
neonat
infecti
diseas
circul
matern
antibodi
interfer
neonat
abil
develop
immun
refer
matern
interfer
colostrum
compos
mainli
transport
across
mucos
epithelium
upper
respiratori
tract
although
iga
cross
mucosa
dimer
iga
make
antibodi
colostrum
suggest
upper
respiratori
tract
may
affect
matern
interfer
test
hypothesi
cow
vaccin
modifi
live
bovin
viral
diarrhea
viru
bvdv
vaccin
compos
brsv
antigen
calv
shown
high
circul
matern
deriv
igg
antibodi
serum
extrem
low
titer
matern
deriv
igg
nasal
secret
matern
deriv
iga
nasal
secret
present
much
lower
level
serum
calv
day
old
either
vaccin
bvdv
receiv
one
two
day
day
immun
intranas
rout
within
day
birth
matern
deriv
iga
nasal
secret
detect
calfderiv
ie
endogen
iga
product
detect
within
day
vaccin
secondari
intranas
vaccin
week
induc
strong
memori
antibodi
respons
sustain
iga
level
nasal
secret
collect
studi
demonstr
mucos
immun
system
newborn
calv
function
respons
vaccin
without
affect
matern
interfer
chicken
turkey
duck
avian
barn
hous
popul
larg
number
bird
egg
product
product
meat
standard
lay
hous
report
hold
hen
broiler
hous
routin
hous
bird
number
surpris
industri
activ
sought
vaccin
could
administ
mucos
rout
rather
parenter
rout
gener
reli
inject
needl
major
mucos
avian
vaccin
live
virus
administ
eyedropp
eye
intraocular
conjunctiv
oral
drink
water
coars
spray
wherebi
bird
consum
vaccin
preen
ovo
rout
infe
oral
vaccin
spray
cabinet
intranas
rout
also
use
commerci
vaccin
ovo
inject
becom
wide
use
mean
deliv
precis
uniform
dose
capac
inject
egg
per
hour
ovo
immun
ad
benefit
method
avoid
stress
chick
sanitari
earlier
exposur
time
immun
method
mani
experiment
mucos
avian
vaccin
develop
combat
avian
influenza
report
intranas
deliv
bioadhes
liposom
use
tremella
xanthan
gum
contain
experiment
inactiv
avian
viru
model
antigen
elicit
high
mucos
siga
serum
igg
chicken
even
low
pathogen
strain
avian
influenza
viru
aiv
affect
econom
success
commerci
poultri
industri
caus
mild
respiratori
diseas
decreas
egg
product
immun
multipl
form
avian
influenza
way
experiment
vaccin
instanc
lactobacillu
plantarum
strain
engin
express
select
peptid
aiv
oral
intranas
vaccin
white
leghorn
layer
chicken
succeed
induc
immun
intranas
rout
induc
stronger
immun
show
less
bodi
weight
loss
lung
viru
titer
patholog
challeng
viru
nontradit
mucos
vaccin
deliveri
platform
show
may
good
choic
commerci
avian
influenza
vaccin
develop
rabbit
hemorrhag
diseas
rhd
lethal
diseas
adult
rabbit
caus
rabbit
caliciviru
oral
immun
rabbit
recombin
vaccinia
viru
recombin
myxoma
viru
code
major
structur
protein
rhd
viru
rhdv
induc
protect
challeng
virul
rhdv
howev
littl
horizont
transfer
achiev
research
show
oral
immun
protein
express
transgen
potato
gener
partial
protect
viral
challeng
rabbit
use
investig
whether
uteru
suitabl
mucos
vaccin
site
experiment
vaccin
consist
ovalbumin
ova
recombin
truncat
glycoprotein
bovin
herp
viru
fusion
protein
porcin
parvoviru
bacteri
thioredoxin
formul
poli
c
host
defens
peptid
polyphosphazen
adjuv
surgeri
perform
isol
uterin
horn
tripl
adjuv
vaccin
inject
lumen
uterin
horn
refer
intrauterin
immun
signific
induct
ova
tgdspecif
serum
igg
iga
observ
time
intrauterineimmun
anim
uterin
lung
vagin
tissu
obtain
month
singl
immun
show
signific
ovaspecif
igg
iga
respons
rel
sham
treatment
significantli
increas
tgdspecif
antigenspecif
igg
titer
iga
titer
observ
lung
vagina
uterin
tissu
rel
control
result
indic
subunit
vaccin
formul
appropri
adjuv
trigger
system
mucos
immun
administ
uterin
lumen
mani
wild
koala
australia
known
chlamydia
pecorum
caus
debilit
ocular
urogenit
infect
koala
clinic
sign
includ
conjunct
infertil
singledos
antic
pecorum
vaccin
formul
contain
three
major
outermembran
protein
momp
polymorph
membran
protein
pmp
antigen
membran
bound
surfaceexpos
adhes
protein
import
attach
cell
membran
ratio
pcep
poli
di
sodium
carboxylatoethylphenoxi
phosphazen
immun
defens
regulatori
peptid
poli
c
test
wild
koala
although
vaccin
administ
subcutan
antimomp
iga
increas
ocular
upper
genit
tract
ugt
site
koala
respect
pmpg
vaccin
also
trigger
increas
post
vaccin
iga
antibodi
ugt
ocular
site
koala
respect
suggest
vaccin
elicit
mucos
respons
least
koala
cohort
vaccin
momp
vaccin
show
decreas
chlamydia
load
new
occurr
infect
vaccin
group
control
group
show
increas
load
incid
new
infect
suggest
momp
vaccin
may
superior
develop
must
undertaken
improv
vaccin
uptak
member
popul
result
suggest
parenter
vaccin
may
succeed
promot
mucos
respons
properli
formul
sylvat
plagu
caus
yersinia
pesti
carri
flea
significantli
affect
popul
dynam
prairi
dog
cynomi
spp
turn
reduc
prairi
dog
number
affect
popul
dynam
ferret
burrow
owl
sever
canin
avian
predat
administr
insecticid
control
flea
reduc
transmiss
pesti
evid
flea
develop
resist
vaccin
use
altern
use
insecticid
activ
sought
orthopoxviru
raccoonpox
rcn
genet
modifi
express
two
protect
pesti
antigen
design
mix
bait
oral
vaccin
prairi
dog
lab
set
sixti
percent
prairi
dog
consum
bait
contain
challeng
day
postvaccin
surviv
significantli
higher
percentag
placebo
group
rate
surviv
improv
two
oral
bait
consum
month
apart
rabi
viru
member
rhabdovirida
famili
caus
neuroinvas
rabi
diseas
mani
wild
anim
includ
bat
possum
raccoon
skunk
fox
coyot
groundhog
wolv
monkey
also
infect
companion
anim
dog
cat
rabbit
hors
spread
saliva
transmit
bite
scratch
symptom
includ
fever
violent
movement
uncontrol
excit
fear
water
aggress
behavior
death
human
case
rabi
come
contact
infect
domest
dog
rabor
vrg
oral
vaccin
compos
live
vaccinia
viru
encod
rabi
viru
glycoprotein
encas
packet
fish
meal
set
bait
raccoon
fox
coyot
like
packet
flavor
coat
attract
target
speci
altern
oral
vaccin
canada
onrab
live
adenoviru
vector
encod
rabi
glycoprotein
administ
oral
vaccin
ultralit
bait
matrix
compar
studi
show
rabor
vrg
onrab
distribut
aircraft
densiti
baitskm
sera
raccoon
skunk
collect
week
later
skunk
show
signific
differ
proport
antibodyposit
anim
regardless
vaccin
use
contrast
proport
antibodyposit
raccoon
significantli
higher
onrabbait
area
rabor
vrgbait
area
suggest
onrab
may
better
choic
vaccin
speci
aquacultur
industri
grow
faster
farm
anim
industri
world
increas
million
ton
increasingli
high
proport
highqual
protein
use
feed
world
grow
popul
come
aquacultur
farm
industri
risk
infecti
diseas
increas
densiti
anim
increas
excel
fish
health
manag
practic
control
stock
densiti
maintain
adequ
oxygen
level
water
qualiti
reduc
pathogen
load
critic
control
diseas
improv
understand
mucos
immun
farm
fish
crustacean
may
lead
develop
costeffect
mucos
vaccin
estim
fish
speci
world
extrem
divers
accommod
live
warm
cold
climat
fresh
salt
water
depth
high
low
pressur
teleost
boni
fish
lack
bone
marrow
instead
b
lymphocyt
matur
within
kidney
mucosaassoci
lymphoid
tissu
teleost
fish
compos
skinassoci
lymphoid
tissu
gillassoci
lymphoid
tissu
diffus
gutassoci
lymphoid
tissu
antibodyproduc
cell
identifi
cutan
dermi
mucu
may
indic
mucos
immun
system
fish
yet
clear
whether
fish
b
cell
home
back
mucos
site
upon
mucos
infect
immun
instanc
oral
anal
immun
carp
formalinkil
vibrio
anguillarum
follow
booster
immun
rout
result
slightli
enhanc
antigenspecif
ig
titer
detect
skin
mucu
bile
serum
antibodi
titer
elev
anal
intub
respons
oral
immun
rout
immun
affect
immun
fish
warrant
studi
fish
bodi
temperatur
take
local
temperatur
signific
impact
metabol
rate
growth
fish
well
immun
system
instanc
develop
antibodi
fish
adapt
low
temperatur
c
may
requir
least
week
wherea
time
period
develop
antibodi
may
week
fish
adapt
warmer
temperatur
time
frame
suggest
even
fish
function
immun
system
may
develop
immun
time
manner
protect
infect
major
caus
agent
infecti
diseas
finfish
aquacultur
includ
bacteria
virus
parasit
fungi
infecti
agent
infect
fish
development
stage
other
although
fish
may
function
immun
system
larva
fri
stage
other
may
mean
proper
biosecur
rather
vaccin
may
critic
protect
infect
farm
fish
routin
vaccin
includ
atlant
salmon
salmo
salar
rainbow
trout
onchorhynchu
mykiss
atlant
cod
gadu
morhua
effect
vaccin
develop
declin
use
antibiot
along
improv
health
increas
growth
fish
current
three
main
form
vaccin
aquat
speci
immers
oral
deliveri
inject
immers
immun
gill
like
main
site
antigen
entri
uptak
skin
later
line
gut
also
suggest
may
fact
contribut
induct
mucos
immun
immers
vaccin
effect
number
bacteri
pathogen
practic
cheap
easi
batchadminist
especi
small
fish
disadvantag
vaccin
rout
requir
larg
amount
vaccin
level
protect
durat
immun
may
vari
across
vaccin
experiment
vaccin
immers
catfish
day
posthatch
modifi
live
edwardsiella
ictaluri
vaccin
shown
produc
protect
immun
respons
enter
septicemia
research
show
introduc
sever
small
lesion
skin
immers
fish
vaccin
suspens
contain
formalinkil
streptococcu
inia
produc
protect
immun
respons
bacteria
suggest
respons
equal
effect
produc
intraperiton
inject
oral
deliveri
accomplish
fish
age
rel
cheap
nonlaborintens
stress
fish
option
deliv
vaccin
fish
seawat
growth
stage
disadvantag
includ
fact
larg
quantiti
antigen
requir
imposs
ensur
equal
distribut
among
farm
anim
durat
immun
gener
less
observ
inject
immers
oral
vaccin
made
adher
finish
feed
challeng
maintain
antigen
stabil
countri
high
heat
humid
well
highacid
environ
stomach
consum
bioencapsul
use
wherein
feed
incub
vaccin
suspens
prior
feed
fri
differ
encapsul
techniqu
includ
formul
liposom
algin
bead
use
protect
antigen
destruct
environ
gut
anim
oral
administr
may
lead
induct
toler
may
compound
young
age
anim
repeat
lowdos
administr
research
believ
oral
vaccin
may
suit
act
booster
immun
avoid
induct
oral
toler
howev
studi
shown
primari
oral
vaccin
salmon
seawat
growth
stage
oral
salmonid
rickettsi
septicemia
vaccin
formul
bioadhes
cation
polysaccharid
protect
salmon
lethal
pathogen
challeng
research
show
oral
vaccin
dna
vaccin
wherein
vector
express
gene
infecti
pancreat
necrosi
viru
encapsul
algin
microspher
protect
salmonid
fish
infecti
challeng
oral
vaccin
rainbow
trout
experiment
vaccin
bacterin
yersinia
ruckeri
fail
protect
enter
redmouth
diseas
yersiniosi
dose
administ
anal
protect
infecti
challeng
data
suggest
oral
vaccin
need
protect
degrad
stomach
effect
rainbow
trout
mykiss
vaccin
intranas
earli
day
posthatch
live
attenu
infecti
hematopoiet
necrosi
viru
vaccin
kill
enter
red
mouth
bacterin
salin
upon
challeng
respect
pathogen
day
later
vaccin
group
significantli
protect
agematch
mock
control
group
data
suggest
intranas
rout
may
amen
vaccin
target
becom
adapt
mass
vaccin
mani
farm
fish
vaccin
intraperiton
inject
rout
labor
intens
method
also
stress
fish
must
perform
fish
suffici
size
mean
vaccin
fri
difficult
commerci
mucos
vaccin
avail
virus
infect
fish
vaccin
administ
inject
rise
aquacultur
come
increas
need
protect
livestock
infecti
diseas
increas
effort
elucid
immunolog
target
speci
fish
pathogenesi
parasit
viru
bacteria
target
undoubtedli
lead
develop
new
vaccin
suitabl
mass
deliveri
popul
manag
differ
consider
depend
whether
speci
interest
wildlif
pest
companion
anim
zoo
anim
gener
pest
speci
ideal
immunocontracept
would
revers
safe
longlast
costeffect
speci
reduct
sexual
aggress
behavior
may
benefici
side
effect
contracept
speci
may
requir
behavior
maintain
herd
hierarchi
therefor
speciesspecif
need
consider
vaccin
decad
two
reliabl
parenter
immunocontracept
gonadotropinreleas
hormon
gnrh
also
known
lutein
hormon
releas
hormon
zona
pellucida
protein
zp
use
revers
control
fertil
mani
anim
speci
antibodi
gener
gnrh
neutral
pituitari
hormon
turn
inhibit
steroidogenesi
gametogenesi
male
femal
mammal
porcin
zona
pellucida
vaccin
prepar
use
zp
isol
pig
ovari
recombin
zp
antigen
spayvac
immunovaccin
technolog
canada
one
studi
immunocontracept
vaccin
wildlif
antizp
antibodi
bound
sperm
imped
bind
penetr
ovum
antizp
antibodi
interfer
follicl
develop
speci
overwhelm
major
immunocontracept
vaccin
deliv
parenter
experiment
research
focus
deliveri
mucos
rout
deliveri
effect
mucos
vaccin
ie
reli
inject
dart
wildlif
zoo
anim
would
ideal
administr
would
less
stress
anim
present
less
risk
person
administ
vaccin
experiment
work
rabbit
show
rabbit
zp
glycoprotein
b
deliv
infect
myxoma
viru
result
infertil
femal
rabbit
brushtail
possum
trichosuru
vulpecula
vaccin
bacteri
ghost
bg
express
zp
protein
introduc
oral
intranasalconjunctiv
parenter
intraduoden
rout
antizp
antibodi
detect
serum
ovarian
follicular
fluid
intranasalconjunctiv
immun
intraduoden
oral
administr
vaccin
elicit
signific
system
immun
respons
indic
protect
bg
vaccin
degrad
gastric
acid
would
enhanc
effect
oral
deliv
vaccin
superovul
artifici
insemin
use
assess
effect
immun
bgdeliv
zp
immun
nasalconjunctiv
rout
result
induc
antibodymedi
cellmedi
immun
respons
significantli
fewer
egg
fertil
immun
possum
femal
field
trial
need
perform
determin
whether
mucos
immun
bg
contain
possum
zp
antigen
suitabl
fertil
control
wild
possum
popul
adopt
use
mucos
immunocontracept
vaccin
must
effect
target
anim
limit
effect
nontarget
anim
may
includ
human
consum
meat
egg
milk
target
speci
zoo
anim
captiv
african
asian
eleph
alter
sex
hormon
level
male
femal
may
advantag
reduc
aggress
musth
season
alter
also
interfer
domin
hierarchi
herd
may
advantag
use
oral
bait
deliveri
system
possibl
design
way
reduc
consumpt
unintend
target
speci
econom
practic
vaccin
develop
cost
associ
manufactur
licens
well
cost
associ
treatment
includ
labor
equip
popul
dynam
determin
whether
control
fertil
vaccin
effect
mean
control
popul
instanc
research
show
annual
control
campaign
use
bait
steril
femal
fox
would
reduc
red
fox
popul
densiti
annual
campaign
poison
would
reduc
fox
densiti
vaccin
would
cours
better
choic
anim
welfar
issu
taken
consider
although
less
effect
mean
control
popul
growth
whether
popul
control
immunocontracept
cull
depend
speci
avail
effect
mucos
vaccin
mucos
deliveri
system
addit
contracept
immun
select
target
may
use
improv
fertil
activ
immun
cow
inhibin
protein
whose
major
action
neg
feedback
regul
pituitari
folliclestimul
hormon
fsh
secret
via
subcutan
rout
neutral
endogen
inhibin
level
result
increas
fsh
secret
estrou
cycl
immun
cow
greater
number
follicular
wave
greater
number
follicl
estrou
cycl
could
use
potenti
sourc
oocyt
use
vitro
fertil
embryo
transfer
program
advanc
made
mucos
deliv
inhibin
vaccin
buffalo
nasal
immun
dna
vaccin
code
inhibin
deliv
attenu
salmonella
cholerasui
shown
improv
follicl
develop
fertil
howev
buffalo
trial
underw
estrou
synchron
would
feasibl
wild
investig
establish
feasibl
fertil
vaccin
immun
select
target
may
affect
fertil
care
taken
target
natur
protein
may
affect
pathway
import
anim
health
ovul
rate
affect
must
establish
increas
number
dam
suffer
complic
associ
multipl
offspr
per
parturit
known
vaccin
safe
use
veterinari
vaccin
also
use
reduc
foodborn
ill
target
bacteria
caus
ill
mild
ill
anim
harm
human
upon
consumpt
exampl
chick
oral
immun
first
day
life
boost
oral
via
intramuscular
rout
week
age
novel
attenu
salmonella
enteridi
vaccin
candid
show
significantli
higher
plasma
igg
intestin
siga
level
compar
control
group
lymphocyt
prolifer
respons
cell
number
peripher
blood
vaccin
group
significantli
increas
bird
challeng
intraven
virul
enteritidi
strain
week
egg
contamin
rate
significantli
reduc
vaccin
group
rel
control
total
protect
achiev
result
indic
vaccin
may
reduc
incid
egg
contamin
therefor
reduc
risk
human
salmonellosi
rare
shiga
toxinproduc
escherichia
coli
stec
seriou
consequ
young
age
human
popul
includ
hemorrhag
coliti
renal
failur
death
cattl
wide
recogn
import
reservoir
stec
human
exposur
make
contamin
beef
potenti
sourc
foodborn
infect
parenter
vaccin
combin
antigen
associ
type
iii
secret
systemmedi
adher
result
significantli
reduc
shed
oral
infect
anim
yet
mucos
vaccin
develop
significantli
reduc
colon
cattl
potenti
poor
crossprotect
across
stec
strain
veterinari
mucos
vaccin
protect
human
foodborn
infecti
diseas
tremend
one
health
implic
anticip
number
vaccin
continu
grow
futur
exampl
chapter
demonstr
mucos
vaccin
part
routin
immun
practic
veterinari
medicin
mani
year
research
underway
improv
vaccin
use
novel
adjuv
better
deliveri
system
effect
target
site
uptak
mucos
surfac
howev
import
note
vaccin
extrem
costeffect
penni
per
dose
use
part
mass
vaccin
poultri
fish
thu
one
would
hope
human
vaccin
manufactur
regul
recogn
benefit
potenti
technolog
offer
start
develop
mucos
vaccin
human
costeffect
price
vaccin
alreadi
avail
mucos
administr
human
mucos
vaccin
unfortun
yet
becom
part
routin
immun
practic
human
